Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Anidulafungin Followed by Oral Azole for Candidemia and Invasive Candidiasis
NCT00496197Phase 4Completed
- Sponsor
- Pfizer
- Start
- Jul 2007
- Primary completion
- Jun 2010
- Modality
- Small Molecules, Cyclic Peptides
- Countries
- 2
01
Overview
A Phase 4 trial of anidulafungin in candidemia, invasive candidiasis, sponsored by Pfizer. Started Jul 2007; status: completed.
02
Drugs
anidulafungin
03
Conditions
candidemiainvasive candidiasis
Beyond the preview
Go deeper on NCT00496197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496197.